Controllability estimation in Parkinson's disease: role of dopamine

Controllability estimation in Parkinson's disease: role of dopamine - Controllability estimation in Parkinson

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON56646

Enrollment

Registered

2024-03-21

Start date

2025-02-14

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological disorder Parkinson's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Age >= 18 years • Disease duration

Exclusion criteria

Exclusion criteria: o Taking any other dopaminergic medication to treat their symptoms (except decarboxylase inhibitor) o Have other neurological diagnosis (such as stroke, epilepsy and dementia) o Taking anti-depressants such as SSRI's. o Negative indications for MRI o Incompatible medical devices (e.g. pacemaker) o Incompatible metal implants o Claustrophobia o If you are pregnant or suspect that you are pregnant

Design outcomes

Primary

Measure	Time frame
Behavioral estimation of controllability between study sessions and BOLD response differences related to behavioral manipulations of the task between study sessions.	—

Countries

Netherlands

Outcome results